Logo
Please rotate your device

Landscape orientation recommended.

Menu

No results found.

ALB
Albemarle Corporation – NYSE
Weekly Share Price & Valuation Overview
Market Overview
Open
81.2700
Close
82.1900
High
82.7100
Low
81.1000
Trend
0.27887

Albemarle Corporation

United States • NYSE - New York Stock Exchange • ALB • Currency: USD

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics, organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Key strengths
  • Earnings growth ≥10% supports improving profitability trajectory.
  • Quick ratio ≥1.0 indicates obligations can be met without inventory.
Potential weaknesses
  • Debt/EBITDA >4 — elevated leverage vs earnings capacity.
  • Negative free cash flow — operations may rely on external financing.
Scale & Structure Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
Market Cap Total equity value of the company (share price × shares outstanding).
USD 9.67B
Enterprise Value Operating value: market cap + total debt − cash.
USD 14.11B
Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
USD 4.99B
Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
USD 407.65M
EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
USD 473.20M
Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
USD 42.46
EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
-9.33
Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
1.97%
Shares Outstanding
117.68M
Float Shares
117.11M
Implied Shares Outstanding
117.68M
Profitability & Efficiency TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
4.15%
EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
9.48%
Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
8.16%
Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-18.61%
ROA Return on assets: net income ÷ total assets.
-0.64%
ROE Return on equity: net income ÷ shareholder equity.
-8.11%
Growth Growth rates are YoY unless labeled QoQ.
Revenue Growth Year-over-year revenue growth.
-7.00%
Earnings Growth (YoY) Strong Year-over-year earnings growth.
26.88%
Liquidity & Solvency Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
1.38
Debt to Equity Total debt ÷ shareholder equity; leverage.
0.36
Total Cash Cash and equivalents.
USD 1.81B
Total Debt Short + long-term interest-bearing debt.
USD 3.75B
Net Debt Total debt − cash (negative = net cash).
USD 1.94B
Debt / EBITDA Leverage relative to operating earnings; lower is safer.
7.92
Cash Flow Shown only when internally consistent; margins are TTM.
Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
USD 775.10M
Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
USD -251.35M
OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
15.52%
FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-5.03%
Cash Conversion (OpCF/EBITDA)
1.64
Sharemaestro House View
Risk: 1 Sharemaestro internal risk profile (0–3, higher is safer). Composite Score: 1 Overall internal composite (0–3, higher is better). Suggested Allocation: 1.67% Indicative portfolio weighting suggestion based on house view.
Structural Insights (experimental)
Ownership & Liquidity
Free Float Proportion of shares available for public trading. 99.5%
Insiders Shares held by company insiders (officers, directors). 0.4%
Institutions Shares held by institutions (funds, pensions). 98.2%
Capital Structure
Potential Dilution Increase in share count if options/convertibles exercise.
None detected
Net Debt Total debt − cash (negative = net cash).
USD 1.94B
38.8% of revenue Net debt relative to revenue — debt load vs business scale.
Resilience Score 0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating. 63
Methodology Notes
  • Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
  • Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 03:48

Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.

AI generated insights not available yet. Sign in to generate the snapshot.